NYC Restaurant Serves “GLP-1 Meal”
Max Tucci, a media personality and restaurateur, has shared how his New York City eatery, Tucci, is catering to users of weight loss medications, specifically those using GLP-1 drugs like Ozempic. This trend was discussed on “Fox & Friends Weekend.”
Medical experts indicate that drugs like Ozempic are not only changing the physical appearance of users but also altering their eating habits. A recent Bloomberg Intelligence report highlights that Americans on GLP-1 medications are increasingly opting to cook at home rather than eating out. In fact, a significant 54% of 1,000 surveyed users noted they have been eating “significantly fewer” meals from restaurants since beginning their treatment, with a similar proportion reducing their takeout orders.
Interestingly, around 70% of those surveyed mentioned they’ve relied more on home-cooked meals since starting GLP-1 drugs, as reported by Fortune Magazine. These medications, aimed at regulating blood glucose levels and treating type 2 diabetes, also slow digestion and suppress appetite, leading users to choose smaller portions and more nutritious meals.
According to Fair Health, about 4% of adults in the U.S. are currently prescribed GLP-1 drugs for weight management or diabetes, a marked increase in prescriptions for obesity treatments, rising nearly 600%.
“The restaurant portion sizes seem overwhelming now,” noted Dr. Fernando Oval Jr., an expert in obesity medicine based in Florida. He observed many patients struggling to finish even a third of their typical orders.
As these patients reevaluate their food choices, calorie-dense options such as deep-fried dishes and rich desserts are less appealing. Many report opting to share entrees, skip appetizers, and avoid sugary drinks altogether.
Some anecdotal evidence suggests that these medications may also lead to a decrease in alcohol consumption. However, a spokesperson for Novo Nordisk mentioned that while they are monitoring alcohol-related outcomes in clinical trials, the primary focus has been on the medication’s other health impacts.
Meanwhile, a Morgan Stanley report indicated that 63% of GLP-1 users placed fewer food orders during the spring months. According to Dr. Ovalle, patients are making different food choices, favoring proteins, vegetables, and whole foods over high-sugar, high-fat options.
“A smaller appetite doesn’t necessarily mean losing business,” he said. Restaurants can adapt by updating their menus and offering smaller portion options that focus on protein and vegetables, along with clear nutritional information.
Tucci, for example, serves smaller-sized portions of Italian favorites, accommodating those on GLP-1 medications. Tucci shared how customers often ask for smaller portions, reflecting a broader shift in dining habits.
Interestingly, a recent survey noted that many people, particularly younger generations, are opting to order from children’s menus or share appetizers to save costs, reflecting the changing landscape of dining in America.
Challenges such as labor shortages and fluctuating tariffs may also add to the decreased spending patterns seen across different income levels, according to Bloomberg Intelligence. While Novo Nordisk did not elaborate on how their medication might affect dietary choices, a spokesperson reaffirmed its effectiveness for managing obesity and improving health outcomes.
“We take pride in the advancements made to improve the lives of those struggling with chronic conditions like diabetes and obesity,” the spokesperson added, highlighting the positive impact of medications like Ozempic and Wegovy on many Americans.
